ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO517

A Case of Fanconi Syndrome with Biopsy-Proven Acute Proximal Tubular Injury Induced by a Dietary Supplement, Benikoji

Session Information

Category: Fluid, Electrolytes, and Acid-Base Disorders

  • 1102 Fluid, Electrolyte, and Acid-Base Disorders: Clinical

Authors

  • Habuka, Masato, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
  • Hosojima, Michihiro, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
  • Kabasawa, Hideyuki, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
  • Ogawa, Asa, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
  • Ito, Yumi, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
  • Yamamoto, Suguru, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
  • Saito, Akihiko, Niigata Daigaku Igakubu Igakuka Daigakuin Ishigaku Sogo Kenkyuka, Niigata, Niigata, Japan
Introduction

Fanconi syndrome is a common consequence of drug-induced nephrotoxicity characterized by diffuse injury of the proximal tubules that results in the malabsorption of various electrolytes and substances. However, cases of dietary supplement-induced Fanconi syndrome are rare and there is no report on renal histology in these patients. Herein, we present a case of dietary supplement-induced Fanconi syndrome confirmed by renal biopsy.

Case Description

A 49-year-old woman who had been taking a lipid-lowering dietary supplement, Benikoji, was referred to our hospital due to anorexia and nausea over the past 13 days. Blood examinations revealed renal dysfunction, hypokalemia, hypophosphatemia, hypouricemia, and metabolic acidosis. Urinalysis showed proteinuria, glycosuria, hematuria, aminoaciduria, increased excretion of potassium, phosphorus, and uric acid levels, which were not explained by plasma concentration, along with high levels of urinary β2-microglobulin and N-acetyl-beta-D-glucosaminidase. A drug-induced lymphocyte stimulation test of her serum showed positive for the dietary supplement. A percutaneous kidney biopsy was performed on the second day after admission. Light microscopy analysis showed significant tubular changes, with 50% of the tubular epithelial cells showing simplification, vacuolization, and shedding, indicating acute tubular necrosis. Immunohistochemical staining with an anti-megalin antibody, a proximal tubule marker, was positive for the damaged tubules. Acute proximal tubular injury due to the intake of the dietary supplement was found based on her medical history, laboratory examination, and pathological findings, which led to diagnosis of Fanconi syndrome. Her general condition and clinical laboratory data markedly improved after discontinuation of the dietary supplement and correction of dehydration and electrolyte imbalance. She was discharged 14 days after admission.

Discussion

Clinicians should consider dietary supplement-induced Fanconi syndrome as a differential diagnosis if patients are taking dietary supplements. Kidney biopsy is useful for diagnosing and determining the pathogenesis of dietary supplement-induced Fanconi syndrome. However, further reports are warranted to investigate the exact mechanism of dietary supplement-induced Fanconi syndrome.